Skip to main content
. 2024 Jan 17;8(1):zrad128. doi: 10.1093/bjsopen/zrad128

Table 2.

Patient characteristics of subgroups

Colorectal surgery (n = 651) HPB surgery (n = 257)
Controls (n = 507) CMVS (n = 144) P Control (n = 207) CMVS (n = 50) P
Sex 0.502 0.343
 Male 248 (48.9) 75 (52.1) 113 (54.6) 31 (62.0)
 Female 259 (51.1) 69 (47.9) 94 (45.4) 29 (58.0)
Age, mean (s.d.) 67.0 (13.5) 68.6 (12.2) 0.201 66.3 (12.0) 66.4 (11.0) 0.962
Length, mean (s.d.) 172.7 (9.8) 174.0 (10.3) 0.188 173.0 (15.3) 174.5 (9.8) 0.522
Weight, mean (s.d.) 79.1 (16.1) 80.9 (16.0) 0.238 78.6 (15.6) 79.4 (19.5) 0.828
BMI, mean (s.d.) 26.4 (4.8) 26.6 (4.4) 0.553 26.0 (4.4) 26.0 (5.6) 0.948
ASA classification 0.008* 0.449
 1–2 393 (77.5) 96 (66.7) 136 (65.7) 30 (60.0)
 3–4 114 (22.5) 48 (33.3) 71 (34.4) 20 (40.0)
Type 0.011* 0.019*
 Colon/liver 366 (72.2) 119 (82.6) 100 (51.7) 15 (70.0)
 Rectal/pancreas 141 (27.8) 25 (17.4) 107 (48.3) 35 (30.0)
Procedure 0.288 0.883
 Laparoscopic 441 (87.0) 130 (90.3) 81 (39.1) 19 (38.0)
 Open 66 (13.0) 14 (9.7) 126 (60.9) 31 (62.0)
Malignancy 0.563 0.058
 No tumour 103 (20.3) 26 (18.1) 23 (11.1) 9 (18.0)
 Solid tumour 382 (75.3) 109 (75.7) 98 (47.3) 29 (58.0)
 Metastasis 22 (4.3) 9 (6.9) 86 (41.5) 12 (24.0)
CCI, mean (s.d.) 5.4 (2.6) 5.1 (2.3) 0.225 6.8 (3.0) 5.5 (2.9) 0.005*
Preoperative Hb, mean (s.d.) 7.9 (1.1) 7.7 (1.2) 0.038* 8.0 (1.1) 8.0 (1.1) 0.967
Smoking status 0.197 0.002*
 No 202 (39.8) 64 (44.4) 79 (38.2) 11 (22.0)
 Prior 244 (48.1) 70 (48.6) 109 (52.7) 26 (52.0)
 Yes 61 (12.0) 10 (7.0) 19 (9.2) 13 (26.0)
Alcohol use 276 (54.4) 70 (486) 0.216 88 (42.5) 19 (38.0) 0.561
Nutritional status 0.239 0.581
 No malnourishment 439 (86.6) 130 (90.3) 145 (70.0) 37 (74.0)
 Malnourishment 68 (13.4) 14 (9.7) 62 (30.0) 13 (26.0)

Values are n (%) unless otherwise stated. HPB, hepatopancreatobiliary; CMVS, continuous vital signs monitoring intervention; CCI, Charlson Comorbidity Index; Hb, haemoglobin. *Statistically significant.